SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-042699
Filing Date
2023-12-27
Accepted
2023-12-27 16:07:15
Documents
15
Period of Report
2023-12-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20231227.htm   iXBRL 8-K 44463
2 EX-99.1 a202312278kex991.htm EX-99.1 17341
6 frtx-20231227_g1.jpg GRAPHIC 29102
7 image_0a.jpg GRAPHIC 21873
  Complete submission text file 0001628280-23-042699.txt   296449

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20231227.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20231227_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20231227_pre.xml EX-101.PRE 13052
9 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20231227_htm.xml XML 2826
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 231518011
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)